Autor: "Georgescu Margarint EL" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience.
Autorzy:: Biskup E; Department of Basic and Clinical Medicine, Shanghai University of Medicine and Health Sciences, Shanghai 201318, P.R. China.; Department of Advanced Biomedical Sciences, Federico II University of Naples, I-80131 Naples, Italy.; Department of Medical Oncology and Breast Cancer Center, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland.
Sartorius CM; Department of Medical Oncology and Breast Cancer Center, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland.
Müller A; Canton Hospital Winterthur (Med. Oncology), 8400 Winterthur, Switzerland.
Leo C; Department of Gynecology, Canton Hospital Baden, 5404 Baden, Switzerland.
Nussbaum CU; Department of Internal Medicine, Canton Hospital Olten, 4600 Olten, Switzerland.
Georgescu Margarint EL; Shanghai East International Medical Center, Shanghai 200120, P.R. China.
Koychev D; Tumor Center ZeTuP, 8640 Rapperswil, Switzerland.
Schreiber A; Canton Hospital Aarau, 5001 Aarau, Switzerland.
Taverna C; Canton Hospital Muensterlingen, 8596 Münsterlingen, Switzerland.
Thorn D; Oncology Private Practice Basel, Department of Medical Oncology, University Hospital Basel, 4052 Basel, Switzerland.
Vetter M; Medical University Clinic, Canton Hospital Baselland, University of Basel, 4410 Liestal, Switzerland.; Pokaż więcej
Źródło:: Molecular and clinical oncology [Mol Clin Oncol] 2023 May 18; Vol. 19 (1), pp. 52. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment.
Autorzy:: Vetter M; Gynecologic Cancer Center, University Basel, Spitalstrasse 21, 4031 Basel, Switzerland.
Stadlmann S; Department of Pathology, Kantonsspital Baden AG, Im Ergel 1, 5404 Baden, Switzerland.
Bischof E; Department of Basic and Clinical Medicine, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.; Department of Medical Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, China.
Georgescu Margarint EL; Shanghai East International Medical Center, Shanghai 200120, China.
Schötzau A; Ovarian Cancer Research, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland.
Singer G; Department of Pathology, Kantonsspital Baden AG, Im Ergel 1, 5404 Baden, Switzerland.
Heinzelmann-Schwarz V; Gynecologic Cancer Center, University Basel, Spitalstrasse 21, 4031 Basel, Switzerland.; Ovarian Cancer Research, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland.
Montavon C; Gynecologic Cancer Center, University Basel, Spitalstrasse 21, 4031 Basel, Switzerland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Nov 17; Vol. 23 (22). Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:: Journal Article
MeSH Terms:: Cystadenocarcinoma, Serous*/drug therapy
Cystadenocarcinoma, Serous*/pathology
Ovarian Neoplasms*/pathology
Humans ; Female ; Receptors, Progesterone/metabolism ; Receptors, Estrogen/metabolism ; Carrier Proteins ; Carcinoma, Ovarian Epithelial ; Estrogens

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Reduced Interhemispheric Coherence after Cerebellar Vermis Output Perturbation.
Autorzy:: Georgescu Margarint EL; Division of Physiology and Neuroscience, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Georgescu IA; Division of Physiology and Neuroscience, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Zahiu CD; Division of Physiology and Neuroscience, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Șteopoaie AR; Division of Physiology and Neuroscience, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Tirlea SA; Division of Physiology and Neuroscience, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Popa D; Division of Physiology and Neuroscience, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Institut de biologie de l'Ecole normale supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Research University, 75005 Paris, France.
Zagrean AM; Division of Physiology and Neuroscience, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Zagrean L; Division of Physiology and Neuroscience, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.; Pokaż więcej
Źródło:: Brain sciences [Brain Sci] 2020 Sep 08; Vol. 10 (9). Date of Electronic Publication: 2020 Sep 08.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Georgescu Margarint EL"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język